SCS SB 567 & 792 -- Clinical Trials

Sponsor:  Dougherty

This substitute requires health insurers to cover routine patient
care costs incurred as a result of phase II clinical trials for
cancer treatment.  Currently, coverage is only required for phase
III and IV of these trials.

Missouri House of Representatives
93rd General Assembly, 2nd Regular Session
Last Updated November 29, 2006 at 9:46 am